Cargando…

Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study

PURPOSE: The use of carbapenem before and after implementation of an antimicrobial stewardship-led carbapenem-sparing strategy at a tertiary care center in Lebanon was evaluated. METHODS: A retrospective, observational chart review was performed on all hospitalized pediatric and adult patients who r...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Masri, Mira, Haddad, Nisrine, Saad, Therese, Rizk, Nesrine A., Zakhour, Ramia, Kanj, Souha S., Zeenny, Rony M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990088/ https://www.ncbi.nlm.nih.gov/pubmed/35402313 http://dx.doi.org/10.3389/fcimb.2022.729491

Ejemplares similares

1262. The Impact of Antimicrobial Stewardship on Antimicrobial Consumption and Resistance Trends at a Tertiary Care Center in Beirut
por: Haddad, Nisrine, et al.
Publicado: (2023)

1263. The Experience of an Antimicrobial Stewardship Program at a Tertiary Referral Hospital in a Low/Middle Income Country
por: Abdallah, Tamara, et al.
Publicado: (2023)

Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions
por: Rizk, Nesrine A., et al.
Publicado: (2021)

The Impact of Antimicrobial Stewardship and Infection Control Interventions on Acinetobacter baumannii Resistance Rates in the ICU of a Tertiary Care Center in Lebanon
por: Rizk, Nesrine A., et al.
Publicado: (2022)

Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns
por: Schouten, Jeroen, et al.
Publicado: (2021)

Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study
por: Ramia, Elsy, et al.
Publicado: (2014)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
por: Lupia, Tommaso, et al.
Publicado: (2022)

A population-based study of self-reported adverse drug events among Lebanese outpatients
por: Ramia, Elsy, et al.
Publicado: (2021)

Successful establishment and five-year sustainability of a neonatal-specific antimicrobial stewardship program in a low middle-income country
por: Maalouf, Faouzi I., et al.
Publicado: (2023)

Long-Term Carbapenems Antimicrobial Stewardship Program
por: García-Rodríguez, José Francisco, et al.
Publicado: (2020)

Treatment of Piperacillin-Tazobactam–Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials
por: Cao, John, et al.
Publicado: (2023)

Carbapenem-Sparing Strategies for ESBL Producers: When and How
por: Karaiskos, Ilias, et al.
Publicado: (2020)

Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii
por: Lv, Dongmei, et al.
Publicado: (2022)

Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
por: Yoon, Young Kyung, et al.
Publicado: (2014)

The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients
por: Zakhour, Johnny, et al.
Publicado: (2022)

1452. Is Carbapenem-Sparing Therapy as Effective as Carbapenems Against Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in UTI?
por: Hyun, Jonghoon, et al.
Publicado: (2019)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
por: Hu, Dakang, et al.
Publicado: (2022)

Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review
por: Zequinão, Tiago, et al.
Publicado: (2020)

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
por: Peyclit, Lucie, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
por: Sophonsri, Anthony, et al.
Publicado: (2023)

Beyond the Pandemic: The Value of Antimicrobial Stewardship
por: Kanj, Souha S., et al.
Publicado: (2022)

Surgeon-led 7-VINCut Antibiotic Stewardship Intervention Decreases Duration of Treatment and Carbapenem Use in a General Surgery Service
por: Badia, Josep M., et al.
Publicado: (2020)

211. A Comprehensive Assessment of Carbapenem Use across 90 Veterans Health Administration Hospitals with Defined Stewardship Strategies for Carbapenems
por: Suzuki, Hiroyuki, et al.
Publicado: (2020)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains
por: Salloum, Noor A., et al.
Publicado: (2015)

Emergence of Plasmids Co-Harboring Carbapenem Resistance Genes and tmexCD2-toprJ2 in Sequence Type 11 Carbapenem Resistant Klebsiella pneumoniae Strains
por: Li, Xi, et al.
Publicado: (2022)

The Effect of Host Immunity on Predicting the Mortality of Carbapenem-Resistant Organism Infection
por: Lin, Qun, et al.
Publicado: (2020)

Prediction of Prognosis in Adult Patients With Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Chen, Jihui, et al.
Publicado: (2022)

Pathway Driven Target Selection in Klebsiella pneumoniae: Insights Into Carbapenem Exposure
por: Serral, Federico, et al.
Publicado: (2022)

Detection and homology analysis of carbapenem resistant Acinetobacter baumannii resistance gene
por: Huang, Hua-Liang, et al.
Publicado: (2023)

The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the use of antimicrobial therapy in complicated intra-abdominal infections in the era of antimicrobial resistance
por: Haddad, Nicholas, et al.
Publicado: (2019)

Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country
por: Zakhour, Ramia, et al.
Publicado: (2021)

Evaluation of carbapenem use in a tertiary hospital: antimicrobial stewardship urgently needed
por: Zhang, Di, et al.
Publicado: (2019)

Clinical impact of multidisciplinary carbapenem stewardship interventions: a retrospective cohort study
por: Ramadas, Anitha, et al.
Publicado: (2023)

85. The Impact of Carbapenem-Sparing Interventions on the Evolution of Resistance in Pseudomonas aeruginosa in the USA
por: Townsend, Jeffrey, et al.
Publicado: (2020)

Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis
por: Zakhour, Johnny, et al.
Publicado: (2022)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms
por: Zhang, Xiufeng, et al.
Publicado: (2021)

Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains
por: Koskinen, Katariina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_utb77mblq9sn3d8522evleki7t